Advances in RT-LAMP for COVID-19 testing and diagnosis

G Choi, TJ Moehling, RJ Meagher - Expert Review of Molecular …, 2023 - Taylor & Francis
ABSTRACT Introduction The SARS-CoV-2 pandemic, and the subsequent limitations on
standard diagnostics, has vastly expanded the user base of Reverse Transcription Loop …

What is life? Active particles tools towards behavioral dynamics in social-biology and economics

N Bellomo, M Esfahanian, V Secchini, P Terna - Physics of Life Reviews, 2022 - Elsevier
This review paper is devoted to study the conceptual difficulties that mathematics meets
when attempting to describe the complexity of living matter focusing on the challenging …

Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults

HR Wagstaffe, RS Thwaites, A Reynaldi, JK Sidhu… - Science …, 2024 - science.org
Human infection challenge permits in-depth, early, and pre-symptomatic characterization of
the immune response, enabling the identification of factors that are important for viral …

Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of …

TW Russell, H Townsley, S Abbott, J Hellewell… - Plos …, 2024 - journals.plos.org
The emergence of successive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) variants of concern (VOCs) during 2020 to 2022, each exhibiting increased epidemic …

Mechanistic model for booster doses effectiveness in healthy, cancer, and immunosuppressed patients infected with SARS-CoV-2

C Voutouri, CC Hardin, V Naranbhai… - Proceedings of the …, 2023 - National Acad Sciences
SARS-CoV-2 vaccines are effective at limiting disease severity, but effectiveness is lower
among patients with cancer or immunosuppression. Effectiveness wanes with time and …

Treatment of COVID‐19 patients with a SARS‐CoV‐2‐specific siRNA‐peptide dendrimer formulation

M Khaitov, A Nikonova, I Kofiadi, I Shilovskiy… - Allergy, 2023 - Wiley Online Library
Background Severe acute respiratory syndrome corona virus (SARS‐CoV‐2) infection
frequently causes severe and prolonged disease but only few specific treatments are …

Portable microfluidic impedance biosensor for SARS-CoV-2 detection

S Laleh, B Ibarlucea, M Stadtmüller, G Cuniberti… - Biosensors and …, 2023 - Elsevier
Pandemics as the one we are currently facing, where fast-spreading viruses present a threat
to humanity, call for simple and reliable methods to perform early diagnosis, enabling …

Immune response to SARS-CoV-2 in severe disease and long COVID-19

T Sumi, K Harada - Iscience, 2022 - cell.com
COVID-19 is mild to moderate in otherwise healthy individuals but may nonetheless cause
life-threatening disease and/or a wide range of persistent symptoms. The general …

Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study

J Perussolo, MT Teh, N Gkranias, S Tiberi, A Petrie… - Scientific Reports, 2023 - nature.com
This study aimed to evaluate the efficacy of 3 mouthwashes in reducing severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load in the saliva of coronavirus …

Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile

CS Korosec, MI Betti, DW Dick, HK Ooi… - Journal of Theoretical …, 2023 - Elsevier
Abstract Within-host SARS-CoV-2 modelling studies have been published throughout the
COVID-19 pandemic. These studies contain highly variable numbers of individuals and …